Building a successful life sciences real estate company in one country doesn’t guarantee successful expansion into another. But it’s a pretty good place to start. Longfellow Real Estate is the biggest privately owned life sciences real estate company in the U.S., with a 14M SF portfolio valued at about $10B. Now it is looking to establish a long-term presence in the UK by mixing British real estate nous with U.S. life sciences DNA. That means vertical integration, the ability to build from the ground up or convert existing assets, and knowing how to create an ecosystem. “We’re building a team with people that have grown up in the UK real estate market, with the relationships and skills needed to succeed here,” Longfellow UK Managing Director Alex Wright told Bisnow ahead of the UK Life Sciences Real Estate Annual Conference. “But we can complement that with the experience and DNA the U.S. team has in labs and life science, in conversions and ground-up development. 
“That could mean bringing members of the team from the U.S. over here, but the two teams will be completely integrated, and in the UK we’ll be able to tap into the knowledge of 150 people from the U.S. That’s a rare thing.”Longfellow hired Wright at the end of last…  Read the full story here. | 
